col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: eLife Sciences Publications, Ltd.

127 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] eLife 2022―Jun―21 Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination Shaun Truelove, Claire P Smith, Michelle Qin, Luke C Mullany, Rebecca K Borchering, Justin Lessler, et al. (+54)
2 [GO] eLife 2022―Jun―20 Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms Julia M Flynn, Neha Samant, Gily Schneider-Nachum, David T Bakan, Nese Kurt Yilmaz, Celia A Schiffer, et al. (+3)
3 [GO] eLife 2022―Jun―14 Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: a retrospective genomic study Charles N Agoti, Lynette Isabella Ochola-Oyier, Simon Dellicour, Khadija Said Mohammed, Arnold W Lambisia, Zaydah R de Laurent, et al. (+30)
4 [GO] eLife 2022―Jun―10 Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study Guillermo Bosch, Margarita Posso, Javier Louro, Marta Roman, Miquel Porta, Xavier Castells, Francesc Macià
5 [GO] eLife 2022―Jun―06 Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells Ana CG Salina, Douglas dos-Santos, Tamara S Rodrigues, Marlon Fortes-Rocha, Edismauro G Freitas-Filho, Daniel L Alzamora-Terrel, et al. (+37)
6 [GO] eLife 2022―May―19 Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants François Blanquart, Nathanaël Hozé, Benjamin John Cowling, Florence Débarre, Simon Cauchemez
7 [GO] eLife 2022―May―19 SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies Ceri Alan Fielding, Pragati Sabberwal, James C Williamson, Edward JD Greenwood, Thomas WM Crozier, Wioleta Zelek, et al. (+15)
8 [GO] eLife 2022―May―17 Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study Riku Klén, Disha Purohit, Ricardo Gómez-Huelgas, José Manuel Casas-Rojo, Juan Miguel Antón-Santos, Jesús Millán Núñez-Cortés, et al. (+22)
9 [GO] eLife 2022―May―09 A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva Robert Warneford-Thomson, Parisha P Shah, Patrick Lundgren, Jonathan Lerner, Jason Morgan, Antonio Davila, et al. (+6)
10 [GO] eLife 2022―Mar―24 Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2 Mohammad Afsar, Rohan Narayan, Md Noor Akhtar, Deepakash Das, Huma Rahil, Santhosh Kambaiah Nagaraj, et al. (+3)
11 [GO] eLife 2022―Mar―24 Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike Marco A Díaz-Salinas, Qi Li, Monir Ejemel, Leonid Yurkovetskiy, Jeremy Luban, Kuang Shen, et al. (+2)
12 [GO] eLife 2022―Mar―24 The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein Hisham M Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita
13 [GO] eLife 2022―Mar―23 Post-acute sequelae of COVID-19: A metabolic perspective Philipp E Scherer, John P Kirwan, Clifford J Rosen
14 [GO] eLife 2022―Mar―16 Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry Edward R Kastenhuber, Marisa Mercadante, Benjamin Nilsson-Payant, Jared L Johnson, Javier A Jaimes, Frauke Muecksch, et al. (+7)
15 [GO] eLife 2022―Mar―16 Meta-Research: Individual-level researcher data confirm the widening gender gap in publishing rates during COVID-19 Emil Bargmann Madsen, Mathias Wullum Nielsen, Josefine Bjørnholm, Reshma Jagsi, Jens Peter Andersen
16 [GO] eLife 2022―Mar―16 SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome Michela Zaffagni, Jenna M Harris, Ines L Patop, Nagarjuna Reddy Pamudurti, Sinead Nguyen, Sebastian Kadener
17 [GO] eLife 2022―Mar―15 Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike Andrew R Crowley, Harini Natarajan, Andrew P Hederman, Carly A Bobak, Joshua A Weiner, Wendy Wieland-Alter, et al. (+11)
18 [GO] eLife 2022―Mar―11 Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection Noah J Silverstein, Yetao Wang, Zachary Manickas-Hill, Claudia Carbone, Ann Dauphin, Brittany P Boribong, et al. (+11)
19 [GO] eLife 2022―Feb―28 Ribosome profiling of porcine reproductive and respiratory syndrome virus reveals novel features of viral gene expression Georgia M Cook, Katherine Brown, Pengcheng Shang, Yanhua Li, Lior Soday, Adam M Dinan, et al. (+5)
20 [GO] eLife 2022―Feb―09 Inference of the SARS-CoV-2 generation time using UK household data William Stephen Hart, Sam Abbott, Akira Endo, Joel Hellewell, Elizabeth Miller, Nick Andrews, et al. (+3)
21 [GO] eLife 2022―Jan―27 Vaccine-induced COVID-19 mimicry syndrome Eric Kowarz, Lea Krutzke, Marius Külp, Patrick Streb, Patrizia Larghero, Jennifer Reis, et al. (+4)
22 [GO] eLife 2022―Jan―20 What triggers inflammation in COVID-19? Tomohiro Sawa, Takaaki Akaike
23 [GO] eLife 2022―Jan―11 Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection Zaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, Akshay Binayke, Jyotsna Dandotiya, Yashwant Kumar, et al. (+11)
24 [GO] eLife 2021―Dec―20 Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor Tümay Capraz, Nikolaus Ferdinand Kienzl, Elisabeth Laurent, Jan W Perthold, Esther Föderl-Höbenreich, Clemens Grünwald-Gruber, et al. (+10)
25 [GO] eLife 2021―Dec―10 Add mass spectrometry to the pandemic toolbox Bart Van Puyvelde, Maarten Dhaenens
26 [GO] eLife 2021―Nov―25 Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality Mohamed A Badawy, Basma A Yasseen, Riem M El-Messiery, Engy A Abdel-Rahman, Aya A Elkhodiry, Azza G Kamel, et al. (+14)
27 [GO] eLife 2021―Nov―25 The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice Rafael Bayarri-Olmos, Laust Bruun Johnsen, Manja Idorn, Line S Reinert, Anne Rosbjerg, Søren Vang, et al. (+7)
28 [GO] eLife 2021―Nov―23 Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through statistical learning and data mining: Application to COVID-19 related pharmacovigilance Xuan Xu, Jessica Kawakami, Nuwan Indika Millagaha Gedara, Jim Riviere, Emma Meyer, Gerald J Wyckoff, Majid Jaberi-Douraki
29 [GO] eLife 2021―Oct―25 Effect of SARS-CoV-2 proteins on vascular permeability Rossana Rauti, Meishar Shahoha, Yael Leichtmann-Bardoogo, Rami Nasser, Eyal Paz, Rina Tamir, et al. (+9)
30 [GO] eLife 2021―Oct―18 Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score Emirena Garrafa, Marika Vezzoli, Marco Ravanelli, Davide Farina, Andrea Borghesi, Stefano Calza, Roberto Maroldi
31 [GO] eLife 2021―Oct―12 mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status Jason Neidleman, Xiaoyu Luo, Matthew McGregor, Guorui Xie, Victoria Murray, Warner C Greene, et al. (+2)
32 [GO] eLife 2021―Oct―05 HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave Farina Karim, Inbal Gazy, Sandile Cele, Yenzekile Zungu, Robert Krause, Mallory Bernstein, et al. (+18)
33 [GO] eLife 2021―Sep―30 Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective Mona Seifert, Subhas C Bera, Pauline van Nies, Robert N Kirchdoerfer, Ashleigh Shannon, Thi-Tuyet-Nhung Le, et al. (+14)
34 [GO] eLife 2021―Sep―29 mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralisation of P.1 Brazilian variant Helen Parry, Gokhan Tut, Rachel Bruton, Sian Faustini, Christine Stephens, Philip Saunders, et al. (+19)
35 [GO] eLife 2021―Sep―28 Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants Elizabeth Jaworski, Rose M Langsjoen, Brooke Mitchell, Barbara Judy, Patrick Newman, Jessica A Plante, et al. (+18)
36 [GO] eLife 2021―Sep―27 Quantifying the relationship between SARS-CoV-2 viral load and infectiousness Aurélien Marc, Marion Kerioui, François Blanquart, Julie Bertrand, Oriol Mitjà, Marc Corbacho-Monné, et al. (+2)
37 [GO] eLife 2021―Aug―31 Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion Esteban Dodero-Rojas, Jose N Onuchic, Paul Charles Whitford
38 [GO] eLife 2021―Aug―26 Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand the human ACE2 receptor on binding affinity and kinetics Michael I Barton, Stuart A MacGowan, Mikhail A Kutuzov, Omer Dushek, Geoffrey J Barton, P Anton van der Merwe
39 [GO] eLife 2021―Aug―24 Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections Christopher JR Illingworth, William L Hamilton, Ben Warne, Matthew Routledge, Ashley Popay, Chris Jackson, et al. (+34)
40 [GO] eLife 2021―Aug―20 SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19 Paul Z Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N Fisman, Frank X Gu
41 [GO] eLife 2021―Aug―20 Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia Alex R Schuurman, Tom DY Reijnders, Anno Saris, Ivan Ramirez Moral, Michiel Schinkel, Justin de Brabander, et al. (+6)
42 [GO] eLife 2021―Aug―20 N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 Fang Tian, Bei Tong, Liang Sun, Shengchao Shi, Bin Zheng, Zibin Wang, et al. (+2)
43 [GO] eLife 2021―Aug―13 Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19 Courtney Tindle, MacKenzie Fuller, Ayden Fonseca, Sahar Taheri, Stella-Rita Ibeawuchi, Nathan Beutler, et al. (+15)
44 [GO] eLife 2021―Aug―13 Patterns of within-host genetic diversity in SARS-CoV-2 Gerry Tonkin-Hill, Inigo Martincorena, Roberto Amato, Andrew RJ Lawson, Moritz Gerstrung, Ian Johnston, et al. (+33)
45 [GO] eLife 2021―Aug―13 A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance Mohd Anisul, Jarrod Shilts, Jeremy Schwartzentruber, James Hayhurst, Annalisa Buniello, Elmutaz Shaikho, et al. (+12)
46 [GO] eLife 2021―Aug―12 A comprehensive look at the COVID-19 pandemic death toll Lone Simonsen, Cecile Viboud
47 [GO] eLife 2021―Aug―05 Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy Sierra M Barone, Alberta GA Paul, Lyndsey M Muehling, Joanne A Lannigan, William W Kwok, Ronald B Turner, et al. (+2)
48 [GO] eLife 2021―Aug―03 Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children Alvin X Han, Zandra C Felix Garza, Matthijs RA Welkers, René M Vigeveno, Nhu Duong Tran, Thi Quynh Mai Le, et al. (+22)
49 [GO] eLife 2021―Jul―29 Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains Nikhil Faulkner, Kevin W Ng, Mary Y Wu, Ruth Harvey, Marios Margaritis, Stavroula Paraskevopoulou, et al. (+23)
50 [GO] eLife 2021―Jul―27 Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population Ariel Israel, Alejandro A Schäffer, Assi Cicurel, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, et al. (+4)
51 [GO] eLife 2021―Jul―27 Revisiting the guidelines for ending isolation for COVID-19 patients Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Shoya Iwanami, Ana I Bento, Yasuhisa Fujita, et al. (+7)
52 [GO] eLife 2021―Jul―12 Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time A Sarah Walker, Emma Pritchard, Thomas House, Julie V Robotham, Paul J Birrell, Iain Bell, et al. (+12)
53 [GO] eLife 2021―Jul―06 Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor Hui Liu, Junyi Xin, Sheng Cai, Xia Jiang
54 [GO] eLife 2021―Jun―30 Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset Ariel Karlinsky, Dmitry Kobak
55 [GO] eLife 2021―Jun―29 Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data Oliver Stirrup, Joseph Hughes, Matthew Parker, David G Partridge, James G Shepherd, James Blackstone, et al. (+10)
56 [GO] eLife 2021―Jun―24 Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries Katy A M Gaythorpe, Kaja Abbas, John Huber, Andromachi Karachaliou, Niket Thakkar, Kim Woodruff, et al. (+8)
57 [GO] eLife 2021―Jun―22 Smartphone Screen Testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals Rodrigo M Young, Camila J Solis-Cascante, Andres Barriga-Fehrman, Carlos Abogabir, Alvaro R Thadani, Mariana Labarca, et al. (+13)
58 [GO] eLife 2021―Jun―21 Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice Seungjin Ryu, Irina Shchukina, Yun-Hee Youm, Hua Qing, Brandon Hilliard, Tamara Dlugos, et al. (+11)
59 [GO] eLife 2021―Jun―09 FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip Manoj Kumar, Sneha Gulati, Asgar H Ansari, Rhythm Phutela, Sundaram Acharya, Mohd Azhar, et al. (+9)
60 [GO] eLife 2021―Jun―04 Convalescent plasma use in the United States was inversely correlated with COVID-19 mortality Arturo Casadevall, Quigly Dragotakes, Patrick W Johnson, Jonathon W Senefeld, Stephen A Klassen, R Scott Wright, et al. (+3)
61 [GO] eLife 2021―May―27 A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs Eyad A Qunaibi, Mohamed Helmy, Iman Basheti, Iyad Sultan
62 [GO] eLife 2021―May―18 Avoiding culture shock with the SARS-CoV-2 spike protein Benjamin G Hale
63 [GO] eLife 2021―May―18 Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics Kevin C Ma, Tigist F Menkir, Stephen M Kissler, Yonatan H Grad, Marc Lipsitch
64 [GO] eLife 2021―May―04 Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population Heli Julkunen, Anna Cichońska, P Eline Slagboom, Peter Würtz
65 [GO] eLife 2021―Apr―27 Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses Dylan H Morris, Kwe Claude Yinda, Amandine Gamble, Fernando W Rossine, Qishen Huang, Trenton Bushmaker, et al. (+7)
66 [GO] eLife 2021―Apr―26 High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing William Stephen Hart, Philip K Maini, Robin N Thompson
67 [GO] eLife 2021―Apr―23 SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation David W Sanders, Chanelle C Jumper, Paul J Ackerman, Dan Bracha, Anita Donlic, Hahn Kim, et al. (+13)
68 [GO] eLife 2021―Apr―20 Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population Yuan-Po Tu, Jameel Iqbal, Timothy O'Leary
69 [GO] eLife 2021―Apr―20 Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2 Salwa Naushin, Viren Sardana, Rajat Ujjainiya, Nitin Bhatheja, Rintu Kutum, Akash Kumar Bhaskar, et al. (+130)
70 [GO] eLife 2021―Apr―16 Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols Paul Z Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N Fisman, Frank X Gu
71 [GO] eLife 2021―Apr―09 Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation Mart M Lamers, Anna Z Mykytyn, Tim I Breugem, Yiquan Wang, Douglas C Wu, Samra Riesebosch, et al. (+5)
72 [GO] eLife 2021―Apr―08 Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection Nick K Jones, Lucy Rivett, Shaun Seaman, Richard J Samworth, Ben Warne, Chris Workman, et al. (+10)
73 [GO] eLife 2021―Mar―30 Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage Stefanie Deinhardt-Emmer, Daniel Wittschieber, Juliane Sanft, Sandra Kleemann, Stefan Elschner, Karoline Frieda Haupt, et al. (+11)
74 [GO] eLife 2021―Mar―29 Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers Qing Yang, Nicholas R Meyerson, Stephen K Clark, Camille L Paige, Will T Fattor, Alison R Gilchrist, et al. (+19)
75 [GO] eLife 2021―Mar―23 Rare variants increase the risk of severe COVID-19 Frank L van de Veerdonk, Mihai G Netea
76 [GO] eLife 2021―Mar―23 Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation Florence WJ Chioh, Siew-Wai Fong, Barnaby E Young, Kan-Xing Wu, Anthony Siau, Shuba Krishnan, et al. (+13)
77 [GO] eLife 2021―Mar―17 Genomic and healthcare dynamics of nosocomial SARS-CoV-2 transmission Jamie M Ellingford, Ryan George, John H McDermott, Shazaad Ahmad, Jonathan J Edgerley, David Gokhale, et al. (+4)
78 [GO] eLife 2021―Mar―11 Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, Talat H Malik, Artemis Papadaki, Paige M Mortimer, et al. (+19)
79 [GO] eLife 2021―Mar―08 An open label trial of anakinra to prevent respiratory failure in COVID-19 Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, et al. (+33)
80 [GO] eLife 2021―Mar―08 SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung Alan E Mast, Alisa S Wolberg, David Gailani, Michael R Garvin, Christiane Alvarez, J Izaak Miller, et al. (+2)
81 [GO] eLife 2021―Mar―05 Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys Daniel B Larremore, Bailey K Fosdick, Kate M Bubar, Sam Zhang, Stephen M Kissler, C Jessica E Metcalf, et al. (+2)
82 [GO] eLife 2021―Mar―02 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Chiara Fallerini, Sergio Daga, Stefania Mantovani, Elisa Benetti, Nicola Picchiotti, Daniela Francisci, et al. (+19)
83 [GO] eLife 2021―Mar―02 Genomic epidemiology of COVID-19 in care homes in the East of England William L Hamilton, Gerry Tonkin-Hill, Emily R Smith, Dinesh Aggarwal, Charlotte J Houldcroft, Ben Warne, et al. (+31)
84 [GO] eLife 2021―Feb―23 COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest Albert Tian Chen, Kevin Altschuler, Shing Hei Zhan, Yujia Alina Chan, Benjamin E Deverman
85 [GO] eLife 2021―Feb―23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events Ashish Goyal, Daniel B Reeves, E Fabian Cardozo-Ojeda, Joshua T Schiffer, Bryan T Mayer
86 [GO] eLife 2021―Feb―16 Antimicrobial resistance and COVID-19: Intersections and implications Gwenan M Knight, Rebecca E Glover, C Finn McQuaid, Ioana D Olaru, Karin Gallandat, Quentin J Leclerc, et al. (+5)
87 [GO] eLife 2021―Feb―11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types Zharko Daniloski, Tristan X Jordan, Juliana K Ilmain, Xinyi Guo, Gira Bhabha, Benjamin R tenOever, Neville E Sanjana
88 [GO] eLife 2021―Feb―08 SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets Palur V Raghuvamsi, Nikhil Kumar Tulsian, Firdaus Samsudin, Xinlei Qian, Kiren Purushotorman, Gu Yue, et al. (+6)
89 [GO] eLife 2021―Feb―05 Quantifying the impact of quarantine duration on COVID-19 transmission Peter Ashcroft, Sonja Lehtinen, Daniel C Angst, Nicola Low, Sebastian Bonhoeffer
90 [GO] eLife 2021―Jan―19 Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229E Kathryn E Kistler, Trevor Bedford
91 [GO] eLife 2021―Jan―14 Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2 Kelsey E Huntington, Anna D Louie, Chun Geun Lee, Jack A Elias, Eric A Ross, Wafik S El-Deiry
92 [GO] eLife 2021―Jan―05 Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection Anastasia A Minervina, Ekaterina A Komech, Aleksei Titov, Meriem Bensouda Koraichi, Elisa Rosati, Ilgar Z Mamedov, et al. (+7)
93 [GO] eLife 2021―Jan―04 SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site Anna Z Mykytyn, Tim I Breugem, Samra Riesebosch, Debby Schipper, Petra B van den Doel, Robbert J Rottier, et al. (+2)
94 [GO] eLife 2020―Dec―17 Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring AMR bacterial pneumonia Michaela Gregorova, Daniel Morse, Tarcisio Brignoli, Joseph Steventon, Fergus Hamilton, Mahableshwar Albur, et al. (+24)
95 [GO] eLife 2020―Dec―15 Neutralizing SARS-CoV-2 Eric Poeschla
96 [GO] eLife 2020―Nov―26 A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study Joachim Linssen, Anthony Ermens, Marvin Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar-van der Brugge, et al. (+17)
97 [GO] eLife 2020―Nov―24 COVID-19 research risks ignoring important host genes due to pre-established research patterns Thomas Stoeger, Luís A Nunes Amaral
98 [GO] eLife 2020―Nov―09 ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities Natalia Zamorano Cuervo, Nathalie Grandvaux
99 [GO] eLife 2020―Nov―09 Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes Allen Wang, Joshua Chiou, Olivier B Poirion, Justin Buchanan, Michael J Valdez, Jamie M Verheyden, et al. (+20)
100 [GO] eLife 2020―Oct―28 Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio CC Lorenzi, et al. (+18)
101 [GO] eLife 2020―Oct―26 Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration Qi Yang, Thomas A Hughes, Anju Kelkar, Xinheng Yu, Kai Cheng, Sheldon Park, et al. (+3)
102 [GO] eLife 2020―Oct―12 Early prediction of level-of-care requirements in patients with COVID-19 Boran Hao, Shahabeddin Sotudian, Taiyao Wang, Tingting Xu, Yang Hu, Apostolos Gaitanidis, et al. (+3)
103 [GO] eLife 2020―Oct―01 Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic Chase W Nelson, Zachary Ardern, Tony L Goldberg, Chen Meng, Chen-Hao Kuo, Christina Ludwig, et al. (+2)
104 [GO] eLife 2020―Sep―15 Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions Ilja L Kruglikov, Manasi Shah, Philipp E Scherer
105 [GO] eLife 2020―Sep―07 Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset Benny Borremans, Amandine Gamble, K C Prager, Sarah K Helman, Abby M McClain, Caitlin Cox, et al. (+2)
106 [GO] eLife 2020―Aug―24 The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship Jon C Emery, Timothy W Russell, Yang Liu, Joel Hellewell, Carl AB Pearson, Gwenan M Knight, et al. (+5)
107 [GO] eLife 2020―Aug―21 Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study David W Eyre, Sheila F Lumley, Denise O'Donnell, Mark Campbell, Elizabeth Sims, Elaine Lawson, et al. (+45)
108 [GO] eLife 2020―Aug―20 3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography Marina Eckermann, Jasper Frohn, Marius Reichardt, Markus Osterhoff, Michael Sprung, Fabian Westermeier, et al. (+4)
109 [GO] eLife 2020―Aug―17 Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC) Colin Pawlowski, Tyler Wagner, Arjun Puranik, Karthik Murugadoss, Liam Loscalzo, AJ Venkatakrishnan, et al. (+13)
110 [GO] eLife 2020―Aug―13 Early analysis of the Australian COVID-19 epidemic David J Price, Freya M Shearer, Michael T Meehan, Emma McBryde, Robert Moss, Nick Golding, et al. (+7)
111 [GO] eLife 2020―Jul―30 Neuropathogenesis of SARS-CoV-2 infection Shumayila Khan, James Gomes
112 [GO] eLife 2020―Jul―14 Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? Roger Pique-Regi, Roberto Romero, Adi L Tarca, Francesca Luca, Yi Xu, Adnan Alazizi, et al. (+3)
113 [GO] eLife 2020―Jul―07 Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis Tyler Wagner, FNU Shweta, Karthik Murugadoss, Samir Awasthi, AJ Venkatakrishnan, Sairam Bade, et al. (+26)
114 [GO] eLife 2020―Jul―07 A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm Mike R Garvin, Christiane Alvarez, J Izaak Miller, Erica T Prates, Angelica M Walker, B Kirtley Amos, et al. (+4)
115 [GO] eLife 2020―Jun―23 Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization PJ Klasse, John P Moore
116 [GO] eLife 2020―Jun―22 Evidence for transmission of COVID-19 prior to symptom onset Lauren C Tindale, Jessica E Stockdale, Michelle Coombe, Emma S Garlock, Wing Yin Venus Lau, Manu Saraswat, et al. (+4)
117 [GO] eLife 2020―Jun―19 Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 Nick K Jones, Lucy Rivett, Dominic Sparkes, Sally Forrest, Sushmita Sridhar, Jamie Young, et al. (+28)
118 [GO] eLife 2020―Jun―15 Meta-Research: COVID-19 medical papers have fewer women first authors than expected Jens Peter Andersen, Mathias Wullum Nielsen, Nicole L Simone, Resa E Lewiss, Reshma Jagsi
119 [GO] eLife 2020―Jun―08 A Global Immunological Observatory to meet a time of pandemics Michael J Mina, C Jessica E Metcalf, Adrian B McDermott, Daniel C Douek, Jeremy Farrar, Bryan T Grenfell
120 [GO] eLife 2020―May―28 Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors AJ Venkatakrishnan, Arjun Puranik, Akash Anand, David Zemmour, Xiang Yao, Xiaoying Wu, et al. (+12)
121 [GO] eLife 2020―May―26 SARS-CoV-2 strategically mimics proteolytic activation of human ENaC Praveen Anand, Arjun Puranik, Murali Aravamudan, AJ Venkatakrishnan, Venky Soundararajan
122 [GO] eLife 2020―May―11 Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission Lucy Rivett, Sushmita Sridhar, Dominic Sparkes, Matthew Routledge, Nick K Jones, Sally Forrest, et al. (+20)
123 [GO] eLife 2020―Apr―27 Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome Frank L van de Veerdonk, Mihai G Netea, Marcel van Deuren, Jos WM van der Meer, Quirijn de Mast, Roger J Brüggemann, Hans van der Hoeven
124 [GO] eLife 2020―Apr―06 Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients Gian Paolo Rossi, Viola Sanga, Matthias Barton
125 [GO] eLife 2020―Mar―31 SARS-CoV-2 (COVID-19) by the numbers Yinon M Bar-On, Avi Flamholz, Rob Phillips, Ron Milo
126 [GO] eLife 2020―Mar―25 Publishing in the time of COVID-19 Michael B Eisen, Anna Akhmanova, Timothy E Behrens, Detlef Weigel
127 [GO] eLife 2020―Feb―24 Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 Katelyn Gostic, Ana C R Gomez, Riley O Mummah, Adam J Kucharski, James O Lloyd-Smith
 [1] 

127 Results       Page 1




[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec